Connect with us
Rare diseases are, despite advances, an important area of development for biomedical research, since only 5% of these pathologies have an available treatment. However, current European...
More than 60% of the €1.27 billion allocated to R&D in 2021 was devoted to clinical trials (€789 million), where Spain plays a prominent international role,...
A new study has confirmed the effectiveness of CBD in treating severe anxiety, this time in a test group of young people. But there are still...
Celyad Oncology—a biotech startup creating a highly specialized treatment for relapsing multiple myeloma patients—has just had its clinical trial validated by the FDA. A major milestone...
Spain become one of the countries with the best conditions to host the research and development of new medicine. To the point that Spanish doctors and...